Literature DB >> 29621216

Low-molecular-weight albumin drug touted for severe osteoarthritis.

Cormac Sheridan.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2018        PMID： 29621216     DOI： 10.1038/nbt0418-293

Source DB:  PubMed          Journal:  Nat Biotechnol        ISSN： 1087-0156            Impact factor:   54.908


× No keyword cloud information.
  3 in total

1.  Low Molecular Weight Fraction of Commercial Human Serum Albumin Induces Morphologic and Transcriptional Changes of Bone Marrow-Derived Mesenchymal Stem Cells.

Authors:  David Bar-Or; Gregory W Thomas; Leonard T Rael; Elizabeth D Gersch; Pablo Rubinstein; Edward Brody
Journal:  Stem Cells Transl Med       Date:  2015-06-03       Impact factor: 6.940

2.  A diketopiperazine fragment of human serum albumin modulates T-lymphocyte cytokine production through rap1.

Authors:  Richard Shimonkevitz; Gregory Thomas; Denetta Sue Slone; Michael Craun; Charles Mains; David Bar-Or
Journal:  J Trauma       Date:  2008-01

3.  The low molecular weight fraction of human serum albumin upregulates COX2, prostaglandin E2, and prostaglandin D2 under inflammatory conditions in osteoarthritic knee synovial fibroblasts.

Authors:  Elizabeth D Frederick; Melissa A Hausburg; Gregory W Thomas; Leonard T Rael; Edward Brody; David Bar-Or
Journal:  Biochem Biophys Rep       Date:  2016-08-12
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.